Significant Development by Varian in Hungary

Varian Medical Systems Hungary engaged in the medical technology sector has implemented radiotherapy technological development in Hungary and expanded its Research and Development centre in Budapest over the last three years. With the R&D project of a total cost of almost EUR 8.5 million, the company has created 30 new high value-added jobs. Hungarian taxpayers contribute to the investment costs with about EUR 1.5 million through a government decision.

In addition to various other uses, the klystron instrument patented in 1937 by the American-based Varian Medical Systems, has enabled the technological revolution of radiotherapy treatments, which are one of the cornerstones of oncotherapy, as well as the development of linear accelerating equipment, the Hungarian Investment Promotion Agency reports.

With over 10,000 employees worldwide, Varian has become one of the most prominent players in the medical technology sector, and the equipment and systems developed and manufactured by the company provide daily treatment to millions of cancer patients around the world. The company now belongs to the German Siemens Group.

Varian established its first Eastern European office in Budapest in 2012, which also has a dynamically growing research and development department. By the end of 2021, the company's headcount will be nearly 300, which is mainly due to the expansion of departments supporting development engineering and business processes.

In the framework of the investment, Varian Medical Systems Hungary Ltd. has implemented radiotherapy technological development in the last 3 years. In Hungary, 11 out of the 13 radiotherapy centres apply Varian technology – prior to 2010, only one hospital had Varian instruments –, enabling the use of state-of-the-art oncotherapy technology in each center.